Galapagos NV
GLPG
#5079
Rank
HK$14.60 B
Marketcap
HK$217.45
Share price
0.00%
Change (1 day)
-2.95%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -HK$3.06

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -HK$3.19. In 2025 the company made an earnings per share (EPS) of HK$44.86 an increase over its 2024 EPS that were of HK$9.14.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$3.06-106.82%
2025HK$44.86390.86%
2024HK$9.14-67.16%
2023HK$27.83-199.64%
2022-HK$27.9399.03%
2021-HK$14.03-68.98%
2020-HK$45.24-298.06%
2019HK$22.84-554.64%
2018-HK$5.02-77.18%
2017-HK$22.02-326.21%
2016HK$9.73-134.19%
2015-HK$28.47-371.34%
2014HK$10.49-445.98%
2013-HK$3.0332.88%
2012-HK$2.28-82.07%
2011-HK$12.73-817.9%
2010HK$1.7712.73%
2009HK$1.57-120.79%
2008-HK$7.56-37.67%
2007-HK$12.1439.64%
2006-HK$8.6928.17%
2005-HK$6.786.25%
2004-HK$6.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.51-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$28.30-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$16.13-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$20.07-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$27.90-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$54.50-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
HK$30.48-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-HK$4.78 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$10.74-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel